Although effective contraceptive methods are available, induced abortion remains important as a means of fertility control all over the world. Considerable efforts have been devoted to the study of and improvements in abortion technology. Further refinements are still possible, however, in terms of greater effectiveness, diminished complications, enhanced technical ease, greater convenience, and lower costs. This is particularly true for second-trimester procedures, where the techniques currently in use result in significantly higher maternal morbidity and mortality compared to first-trimester abortions. For many years the most widely used method for terminating pregnancy in the second trimester has been the intraamniotic administration of hypertonic saline. More recently, however, intraamniotic prostaglandins have been used with increasing frequency and considerable success. At present, the use of PGF2α has been approved by drug safety regulating authorities in approximately 50 countries.
KeywordsCatheter Diarrhea Prostaglandin Perforation Triglyceride
Unable to display preview. Download preview PDF.
- 1.Embrey MP, Hillier K, Mahendran P: Termination of pregnancy by extra-amniotic prostaglandins and the synergistic effect of oxytocin. Adv Bio-sciences 9:507, 1973.Google Scholar
- 2.Bygdeman M, Beguin F, Toppozada M, et al: Intrauterine administration of prostaglandin F2α for induction of abortion. Adv Biosciences 9:525, 1973.Google Scholar
- 7.WHO Prostaglandin Task Force: Single extraamniotic administration of 0.92 mg 15-methyl PGF2α in hyscon for termination of pregnancy in the 10th to 20th week of gestation. An international multicentre study. Am J Obstet Gynecol. 129:597, 1977.Google Scholar
- 8.Karim SMM: Singapore experience with prostaglandin. Routine use and recent advances, in Obstetrical and Gynecological Uses of Prostaglandin, vol 1. Lancaster, England, MTP, 1976, p 127.Google Scholar
- 9.Karim SMM, Ratnam SS: Newer aspects of practical applications of prostaglandins in obstetrics and gynecology, in Kharasch N, Fried J (eds): Biochemical Aspects of Prostaglandins and Thromboxanes. New York, Academic Press, 1977.Google Scholar
- 11.Lauersen NH, Wilson KH: The effects of intra-muscular injections of 15(S), 15-methyl prostaglandin F2α in failed abortion. Fertil Steril 28:381, 1977.Google Scholar
- 14.WHO Prostaglandin Task Force: Comparison of intraamniotic prostaglandin F2α and hypertonic saline for induction of second trimester abortion. Br Med J. 1:1370, 1976.Google Scholar
- 15.WHO Prostaglandin Task Force: Comparison of single intraamniotic injections of 15-methyl prostaglandin F2α and PGF2α for termination of second trimester pregnancy. An international multicentre study. Am J Obstet Gynecol. 129:601, 1977.Google Scholar
- 19.WHO Prostaglandin Task Force: Intramuscular administration of 15-methyl PGF2α for induction of abortion in the 10th to 20th week of pregnancy. Am J Obstet Gynecol. 129:593, 1977.Google Scholar
- 21.Brenner WE, Gruber W, Staurovsky LG, et al: Induction of artificial abortion with intramuscular administration of 15(S), 15-methyl PGE2 and 15(S), 15-methyl PGF2α, in Obstetrical and Gynecological Uses of Prostaglandins, vol 1. Lancaster, England, MTP, 1976, p 175.Google Scholar
- 22.Green K, Bygdeman M, Leader A, et al: Pharmacokinetic studies on 15-methyl prostaglandin F2α and its methylester after administration to the human via various routes for induction of abortion, in Advances in Prostaglandin and Thromboxane Research, vol 2. New York, Raven Press, 1976, p 719.Google Scholar
- 24.Bygdeman M, Borell U, Leader A, et al: Induction of first and second trimester abortion by the vaginal administration, in Advances in Prostaglandin and Thromboxane Research, vol 2. New York, Raven Press, 1976, p 693.Google Scholar
- 31.Brenner WE, Berger GS: Pharmacologic methods of inducing mid-trimester abortion: Risks and benefits, in Sciarra J, Zatuchni GI, Speidel JJ (eds): Risks, Benefits, and Controversies in Fertility Control. Hagerstown, Md., Harper & Row, 1978.Google Scholar